Chang et al., showed that IL-17A deficiency, but not IL-17F deficiency, results in reduced tumor growth and tumor-associated inflammation in the presence and absence of NTHi-induced lung inflammation [121]. The gene discussed is IL17A; the disease is neoplasm.